Benefit of Vitamin D supplementation in treatment of Polycystic ovary syndrome (PCOS)
Not Applicable
- Conditions
- Health Condition 1: null- POLYCYSTIC OVARY SYNDROME
- Registration Number
- CTRI/2018/02/012104
- Lead Sponsor
- Intramural
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All women who have oligomenorrhea, hyperandrogensim (hirsuitism, acne or androgenic alopecia) or USG suggestion of polcystic ovary morphology
Exclusion Criteria
NCAH, Thyroid dysfunction,Systemic disorders and drug intake
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on clinical, biochemical and hormonal parametersTimepoint: 0, 3 and 6 months
- Secondary Outcome Measures
Name Time Method To study the prevalence of vitamin D deficiency in women with PCOS. <br/ ><br>2) To correlate vitamin D levels with various clinical, biochemical and insulin sensitivity parameters of PCOS. <br/ ><br>Timepoint: 0,12,24 WEEKS